Ito T, Shimose S, Saeki I, Takeuchi Y, et al. Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma. J Gastroenterol Hepatol 2025 Nov 14. doi: 10.1111/jgh.70150.
PMID: 41235599